Cargando…

Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients

Failure to maintain segregation of oral and gut microbial communities has been linked to several diseases. We sought to characterize oral-fecal microbiome community coalescence, ectopic extension of oral bacteria, clinical variables contributing to this phenomenon, and associated infectious conseque...

Descripción completa

Detalles Bibliográficos
Autores principales: Franklin, Samantha, Aitken, Samuel L., Shi, Yushi, Sahasrabhojane, Pranoti V., Robinson, Sarah, Peterson, Christine B., Daver, Naval, Ajami, Nadim A., Kontoyiannis, Dimitrios P., Shelburne, Samuel A., Galloway-Peña, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010033/
https://www.ncbi.nlm.nih.gov/pubmed/35433514
http://dx.doi.org/10.3389/fcimb.2022.848580
_version_ 1784687395792224256
author Franklin, Samantha
Aitken, Samuel L.
Shi, Yushi
Sahasrabhojane, Pranoti V.
Robinson, Sarah
Peterson, Christine B.
Daver, Naval
Ajami, Nadim A.
Kontoyiannis, Dimitrios P.
Shelburne, Samuel A.
Galloway-Peña, Jessica
author_facet Franklin, Samantha
Aitken, Samuel L.
Shi, Yushi
Sahasrabhojane, Pranoti V.
Robinson, Sarah
Peterson, Christine B.
Daver, Naval
Ajami, Nadim A.
Kontoyiannis, Dimitrios P.
Shelburne, Samuel A.
Galloway-Peña, Jessica
author_sort Franklin, Samantha
collection PubMed
description Failure to maintain segregation of oral and gut microbial communities has been linked to several diseases. We sought to characterize oral-fecal microbiome community coalescence, ectopic extension of oral bacteria, clinical variables contributing to this phenomenon, and associated infectious consequences by analyzing the 16S rRNA V4 sequences of longitudinal fecal (n=551) and oral (n=737) samples from 97 patients with acute myeloid leukemia (AML) receiving induction chemotherapy (IC). Clustering observed in permutation based multivariate analysis of variance (PERMANOVA) of Bray-Curtis dissimilarity and PCoA plot of UniFrac distances between intra-patient longitudinal oral-stool sample pairs suggested potential oral-stool microbial community coalescence. Bray-Curtis dissimilarities and UniFrac distances were used to create an objective definition of microbial community coalescence. We determined that only 23 of the 92 patients exhibited oral-stool community coalescence. This was validated through a linear mixed model which determined that patients who experienced coalescence had an increased proportion of shared to unique OTUs between their oral-stool sample pairs over time compared to non-coalesced patients. Evaluation of longitudinal microbial characteristics revealed that patients who experienced coalescence had increased stool abundance of Streptococcus and Stenotrophomonas compared to non-coalesced patients. When treated as a time-varying covariate, each additional day of linezolid (HR 1.15, 95% CI 1.06 – 1.24, P <0.001), meropenem (HR 1.13, 95% CI 1.05 – 1.21, P = 0.001), metronidazole (HR 1.13, 95% CI 1.05 – 1.21, P = 0.001), and cefepime (HR 1.10, 95% CI 1.01 – 1.18, P = 0.021) increased the hazard of oral-stool microbial community coalescence. Levofloxacin receipt was associated with a lower risk of microbiome community coalescence (HR 0.75, 95% CI 0.61 – 0.93, P = 0.009). By the time of neutrophil recovery, the relative abundance of Bacteroidia (P<0.001), Fusobacteria (P=0.012), and Clostridia (P=0.013) in the stool were significantly lower in patients with oral-gut community coalescence. Exhibiting oral-stool community coalescence was associated with the occurrence of infections prior to neutrophil recovery (P=0.002), as well as infections during the 90 days post neutrophil recovery (P=0.027). This work elucidates specific antimicrobial effects on microbial ecology and furthers the understanding of oral/intestinal microbial biogeography and its implications for adverse clinical outcomes.
format Online
Article
Text
id pubmed-9010033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90100332022-04-15 Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients Franklin, Samantha Aitken, Samuel L. Shi, Yushi Sahasrabhojane, Pranoti V. Robinson, Sarah Peterson, Christine B. Daver, Naval Ajami, Nadim A. Kontoyiannis, Dimitrios P. Shelburne, Samuel A. Galloway-Peña, Jessica Front Cell Infect Microbiol Cellular and Infection Microbiology Failure to maintain segregation of oral and gut microbial communities has been linked to several diseases. We sought to characterize oral-fecal microbiome community coalescence, ectopic extension of oral bacteria, clinical variables contributing to this phenomenon, and associated infectious consequences by analyzing the 16S rRNA V4 sequences of longitudinal fecal (n=551) and oral (n=737) samples from 97 patients with acute myeloid leukemia (AML) receiving induction chemotherapy (IC). Clustering observed in permutation based multivariate analysis of variance (PERMANOVA) of Bray-Curtis dissimilarity and PCoA plot of UniFrac distances between intra-patient longitudinal oral-stool sample pairs suggested potential oral-stool microbial community coalescence. Bray-Curtis dissimilarities and UniFrac distances were used to create an objective definition of microbial community coalescence. We determined that only 23 of the 92 patients exhibited oral-stool community coalescence. This was validated through a linear mixed model which determined that patients who experienced coalescence had an increased proportion of shared to unique OTUs between their oral-stool sample pairs over time compared to non-coalesced patients. Evaluation of longitudinal microbial characteristics revealed that patients who experienced coalescence had increased stool abundance of Streptococcus and Stenotrophomonas compared to non-coalesced patients. When treated as a time-varying covariate, each additional day of linezolid (HR 1.15, 95% CI 1.06 – 1.24, P <0.001), meropenem (HR 1.13, 95% CI 1.05 – 1.21, P = 0.001), metronidazole (HR 1.13, 95% CI 1.05 – 1.21, P = 0.001), and cefepime (HR 1.10, 95% CI 1.01 – 1.18, P = 0.021) increased the hazard of oral-stool microbial community coalescence. Levofloxacin receipt was associated with a lower risk of microbiome community coalescence (HR 0.75, 95% CI 0.61 – 0.93, P = 0.009). By the time of neutrophil recovery, the relative abundance of Bacteroidia (P<0.001), Fusobacteria (P=0.012), and Clostridia (P=0.013) in the stool were significantly lower in patients with oral-gut community coalescence. Exhibiting oral-stool community coalescence was associated with the occurrence of infections prior to neutrophil recovery (P=0.002), as well as infections during the 90 days post neutrophil recovery (P=0.027). This work elucidates specific antimicrobial effects on microbial ecology and furthers the understanding of oral/intestinal microbial biogeography and its implications for adverse clinical outcomes. Frontiers Media S.A. 2022-03-31 /pmc/articles/PMC9010033/ /pubmed/35433514 http://dx.doi.org/10.3389/fcimb.2022.848580 Text en Copyright © 2022 Franklin, Aitken, Shi, Sahasrabhojane, Robinson, Peterson, Daver, Ajami, Kontoyiannis, Shelburne and Galloway-Peña https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Franklin, Samantha
Aitken, Samuel L.
Shi, Yushi
Sahasrabhojane, Pranoti V.
Robinson, Sarah
Peterson, Christine B.
Daver, Naval
Ajami, Nadim A.
Kontoyiannis, Dimitrios P.
Shelburne, Samuel A.
Galloway-Peña, Jessica
Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
title Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
title_full Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
title_fullStr Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
title_full_unstemmed Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
title_short Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
title_sort oral and stool microbiome coalescence and its association with antibiotic exposure in acute leukemia patients
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010033/
https://www.ncbi.nlm.nih.gov/pubmed/35433514
http://dx.doi.org/10.3389/fcimb.2022.848580
work_keys_str_mv AT franklinsamantha oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT aitkensamuell oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT shiyushi oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT sahasrabhojanepranotiv oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT robinsonsarah oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT petersonchristineb oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT davernaval oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT ajaminadima oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT kontoyiannisdimitriosp oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT shelburnesamuela oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients
AT gallowaypenajessica oralandstoolmicrobiomecoalescenceanditsassociationwithantibioticexposureinacuteleukemiapatients